XIE Jing-wen, SU Tian-de, WEI Yu-ting, LI Ge, WU Jian-zhang, HUANG Li-li. Research progress of antioxidant drugs in myocardial ischemia-reperfusion injuryJ. Acta Pharmaceutica Sinica, 2021,56(7): 1845-1855. doi: 10.16438/j.0513-4870.2020-1988
Citation: XIE Jing-wen, SU Tian-de, WEI Yu-ting, LI Ge, WU Jian-zhang, HUANG Li-li. Research progress of antioxidant drugs in myocardial ischemia-reperfusion injuryJ. Acta Pharmaceutica Sinica, 2021,56(7): 1845-1855. doi: 10.16438/j.0513-4870.2020-1988
shu

Research progress of antioxidant drugs in myocardial ischemia-reperfusion injury

    Abstract
  • Myocardial ischemia-reperfusion injury (MIRI) is one of the most difficulties in the studies of cardiovascular diseases, and excessive reactive oxygen species (ROS) accumulation in cells is the main cause of it. Reducing ROS level by antioxidant drugs to protect cardiomyocytes is being the spotlight on MIRI treatment. In this review, the research progress of antioxidant drugs in myocardial ischemia-reperfusion injury in recent years was summarized.
    • FullText(HTML)
  • loading
    • References (87)
    • Relative Articles
  • Supplements (0)

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return